YahooOctober 16, 2026 at 6:30 AM NY11 Days Ago
Biogen-backed Estuary nabs $93M for kidney disease gene therapy
The Series A round, which was led by RA Capital, will help fund the development of two genetic medicines designed to treat an inherited kidney disorder known as "ADPKD."
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
